PUBLISHER: TechNavio | PRODUCT CODE: 1602050
PUBLISHER: TechNavio | PRODUCT CODE: 1602050
Small Molecule API Market 2024-2028
The small molecule api market is forecasted to grow by USD 67.3 bn during 2023-2028, accelerating at a CAGR of 7.5% during the forecast period. The report on the small molecule api market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by evolving small-molecule api manufacturing scenario in developing countries, increasing number of type ii drug master files (DMFs), and growing need to focus on core competencies.
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 6.8% |
CAGR | 7.5% |
Incremental Value | $67.3 bn |
Technavio's small molecule api market is segmented as below:
By Deployment
By Geographical Landscape
This study identifies the increasing geriatric population as one of the prime reasons driving the small molecule api market growth during the next few years. Also, increasing patent expiries and paradigm shift in api manufacturing will lead to sizable demand in the market.
The report on the small molecule api market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading small molecule api market vendors that include Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Cambrex Corp., Cipla Inc., Corden Pharma International GmbH, Dishman Carbogen Amcis Ltd., Dr Reddys Laboratories Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson Matthey Plc, Lonza Group Ltd., Merck KGaA, Novartis AG, Novasep Holding SAS, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., Viatris Inc., and WuXi AppTec Co. Ltd.. Also, the small molecule api market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: